Success Stories: Senior Scientist in Virginia in the Field of Pharmaceuticals Gets EB-1B Approval

Client’s Testimonial:

Thank you very much for letting me know the wonderful news. I highly appreciate your professional service and happy to introduce you to my friends. Thanks for all your support and good luck with your new petitions.


On April 29th, 2014, we received another EB1B Approval for a Senior Scientist in the field of Pharmaceuticals (Approval Notice)


General Field: Pharmaceuticals

Position at the Time of Case Filing: Senior Scientist

Petitioner: A specialty pharmaceutical company

National Origin: India

Service Center: Texas Service Center (TSC)

State Residing at the Time of Filing: Virginia

Approval Notice Date: April 29, 2014

Processing Time: 5 months, 11 days

 


Case Summary:

At North America Immigration Law Group- WeGreened.com, we recently received an EB1B approval for a Senior Scientist in the field of pharmaceuticals. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB1B petition. His specialized research had focused on developing and discovering drugs that incorporate metal coordination chemistry, along with novel drug delivery systems, which provide more targeted and efficient treatment to reduce side effects and increase the efficacy of pharmaceuticals. His research work had resulted in at least 8 peer-reviewed scholarly articles published in leading journals in the field, 6 filed patents, and 6 conference presentations. Furthermore, the beneficiary had a total of 101 citations by researchers around the world for his publications before filing the petition, clearly signifying the international recognition and prevalent dissemination of his research work. In addition, he had reviewed 25 manuscripts submitted to journals in his field. The petitioner in this case was a specialty pharmaceutical company. His original scientific research contributions are confirmed in the following quote by an independent recommender, “[He] has utilized his unique background in the field of pharmaceuticals to conduct cutting-edge studies that have led to groundbreaking advances and improvements in treatment therapies for some of the most debilitating diseases and conditions. [He] has specialized in drug delivery systems of pharmaceuticals, and has performed groundbreaking research studies that have already improved treatment of ocular disorders, and diabetes.”  It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements.  His petition was approved in 5 months and 11 days.